Research and Clinical Studies
At Phoenix, we strongly believe in evidence based medicine and we work with several universities and institutions including the University of Southampton and Kew Royal Botanic Gardens to provide support for research. We're committed to developing Chinese medicine in the UK and Europe so it is with great pride that we support, supply and fund research and clinical studies.
If you would like to apply for research support, please contact the team with an introductory brief and a member of the team will be in contact firstname.lastname@example.org.
The RUTI Trial - University of Southampton
We've been proudly working with Dr Andrew Flower and his team to supply the RUTI trial with high quality herbal medicine. After extensive research, the team chose us as we are the UK distributer of Jiangyin Tianjiang Pharmaceutical concentrated herbal granules. Tianjiang is the only brand of concentrated herbal medicine that is approved by the NHS and this being due to their unprecedented state of the art research and development department and technology.
Jiangyin Tianjiang Pharmaceutical Co. is a Chinese state approved supplier of dried herbs extracts that also has Good Manufacturing Practice (GMP) certification from the Australian Therapeutic Goods Association (TGA). Every herb used in the trial is collected from either wild or specially cultivated fields in China. These herbs are dried, stored and processed according to traditional methods but using modern methods of production. Each herb supplied has a Certificate of Analysis and is tested for authenticity, heavy metals, microbial and fungal contamination.
The RUTI trial is a multi-centred, 16 week, randomised, double-blind, feasibility study investigating the possible role of Chinese herbal medicine in the treatment of recurrent urinary tract infections (RUTIs). For more information about the study visit the RUTI website.
The ORCHID Study - University of Southampton
From 2012-2013, Phoenix Medical supported and supplied the ORCHID study with herbal medicine. This study was run by Professor George Lewith, Dr Michael Moore, Dr Andrew Flower and Dr Lily Lai, at the University of Southampton. After evaluating a number of factories in Asia, Jiangyin Tianjiang Pharmaceutical Co. was confirmed as the chosen manufacturer of herbal medicine. As a RCHM approved supplier, we were proud to be the sole supplier of Tianjiang herbal concentrated granules to the ORCHID study.
This study involves using Chinese herbal medicines for symptoms and problems experienced by women with polycystic ovary syndrome (PCOS). This study has been funded by the National Institute for Health Research (NIHR), a government research organisation and is led by a team of GPs and researchers from the University of Southampton. This study has now been completed, for more information please visit the ORCHID website. You can find the article in the European Journal of Integrative Medicine.